Reviva Pharmaceuticals, Inc.

États‑Unis d’Amérique

 
Quantité totale PI 45
Rang # Quantité totale PI 30 800
Note d'activité PI 1,6/5.0    7
Rang # Activité PI 133 466
Classe Nice dominante Services scientifiques, technolo...

Brevets

Marques

25 1
2 1
15 0
1
 
Dernier brevet 2024 - Brilaroxazine liposome composition
Premier brevet 2007 - Synthesis, methods of using, and...
Dernière marque 2016 - REVIVA
Première marque 2007 - REVIVA

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 Invention Brilaroxazine liposome composition. The present invention is directed to a liposome composition c...
Invention Method for treating psoriasis. The present invention is directed to a method for treating psorias...
2022 Invention Methods for treating pulmonary fibrosis. The present invention provides a method of using arylpip...
2021 Invention Methods for treating pulmonary fibrosis. The present invention provides a method of using arylpi...
2019 Invention Methods for treating parkinson's disease. The present invention provides a method of using arylp...
2017 Invention Methods for treating pulmonary hypertension. The present invention provides a method of using ary...
Invention Methods for treating alzheimer's disease. The present invention provides a method of using arylp...
Invention Methods for treating psychosis associated with parkinson's disease. The present invention provid...
Invention Arylpiperazine derivatives and methods of utilizing same. The present invention provides arylpipe...
2016 Invention Methods for treating attention deficit hyperactivity disorder. The present invention provides a m...
P/S Pharmaceutical drug discovery and development, namely, clinical trials and consulting services re...
Invention Methods for treating psychosis associated with parkinson's disease. The present invention provide...
Invention Methods for treating alzheimer's disease. The present invention provides a method of using arylpi...
2015 Invention Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives. The presen...
2014 Invention Synthesis, methods of using, and compositions of cycloalkylmethylamines. The present invention pr...
2013 Invention Cycloalkylmethylamines. The present invention provides novel cycloalkylmethylamine derivatives, a...
Invention Methods of using cycloalkylmethylamine derivatives. The present invention provides novel cycloalk...
Invention Methods of utilizing arylpiperazine derivatives. The present invention provides arylpiperazine de...
2012 Invention Compositions, synthesis, and methods of using indanone based cholinesterase inhibitors. The prese...
2011 Invention Methods of using cycloalkylmethylamines. The present invention provides novel cycloalkylmethylami...
Invention Cycloalkylmethylamines. The present invention provides novel cycloalkylmethylamine analogs, and m...
Invention Compositions, synthesis, and methods of using cycloalkylmethylamine derivatives. The present inve...
2010 Invention Compositions, synthesis, and methods of utilizing arylpiperazine derivatives. The present inventi...
Invention Compositions, synthesis, and methods of utilizing quinazolinedione derivatives. The present inven...
2009 Invention Compositions, synthesis, and methods of using piperazine based antipsychotic agents. The present ...
2008 Invention Compositions, synthesis, and methods of using quinolinone based atypical antipsychotic agents. Th...
2007 P/S Pharmaceutical products and preparations for the treatment of central nervous system, cardiovascu...
P/S Pharmaceutical drug research and development, including conducting clinical trials and consulting...